Clinician questions (10)
Discussion questions for a licensed clinician to accept, modify, or reject. Priority meansresearch priority, never clinical urgency.
The full clinician framing — printable packet, prediction / outcome matrix, and the recorded forbidden phrasings — lives on Questions for clinicians.
bone(2)
CQ-001Clinician questionboneresearch priority: highdon’t-miss review priority●Source audited
Would paired bone formation markers (P1NP, bone-specific ALP ± osteocalcin), interpreted with preanalytical standards, help classify turnover before any long-term bone-agent class discussion?
Rationale. Formation markers are not documented in the public ledger; CTX alone (upper-normal, fasting unknown) cannot establish formation–resorption uncoupling. BTM use for monitoring/interpretation and sex-specific reference intervals are the relevant literature (not densitometry-only guidance).
CQ-002Clinician questionboneresearch priority: highdon’t-miss review priority●Source audited
On the next same-scanner DXA, can age-appropriate Z-scores be reported and can hip BMD change be interpreted against a facility-derived LSC? If vertebral fracture assessment (VFA) is considered, does the patient meet formal indication criteria rather than low BMD alone? Trabecular bone score (TBS), if discussed, is per ISCD generally for ages ≥40 with male fracture-risk evidence primarily studied above age 50 — this patient is ~38, so is TBS applicable now, or better deferred?
Rationale. ISCD 2023 Adult Official Positions (lit-0015 / Shuhart et al. J Clin Densitom 2023 doi 10.1016/j.jocd.2023.101435): Z-scores preferred in men <50; osteoporosis cannot be diagnosed on BMD alone under 50; each facility should determine precision error and calculate LSC (manufacturer LSC not a substitute) for serial change; TBS is appropriate in adults ≥40 (male fracture-risk evidence primarily studied above age 50) and routine TBS-change monitoring is not recommended; VFA has formal indication criteria not met by young age + low BMD alone without other triggers. Age ~38 at latest scans — all four points are carried on the lit-0015 card quality_notes/body.
renal bone(1)
CQ-003Clinician questionrenal boneresearch priority: high●Source audited
Is controlled calcium-flux phenotyping (sodium-aware 24h urine with stone profile + fasting urine Ca/Cr + paired serum Ca/PTH/PO4) appropriate to classify hypercalciuria mechanism?
Rationale. Serial 24h urine calcium values 283→254→333 mg/24h in a male (common male threshold often 300 mg/day or 4 mg/kg; 2 of 3 collections below 300; middle value 254 normal at performing lab ref 100–300 vs Litholink 40–250). Mechanism (absorptive vs renal leak vs resorptive) incomplete; high urine Na noted. Counter-consideration from AUA 2014 Statement 7 (Recommendation, Grade C) — clinicians should NOT routinely perform "fast and calcium load" testing to distinguish among types of hypercalciuria, because it has not been shown to change clinical practice — and that guideline population is stone formers, whereas this record documents one lifetime stone, passed spontaneously, and no stones on the CT urogram of 2026-02-27. That is a stone-forming history at its mildest end rather than an absence of one, so the guideline population overlaps this record weakly rather than not at all (COR-0042). Sodium-aware 24-h panel framing (AUA Statement 6) is the better-supported element; mechanism-classification testing remains a research question, not a mandated order.
genetics(1)
CQ-004Clinician questiongeneticsresearch priority: highdon’t-miss review priority●Source audited
Is an early-onset osteoporosis / bone-fragility gene panel appropriate, with counseling that related-cohort pathogenic yields are modest and that variants of uncertain significance may complicate interpretation?
Rationale. Best single-primary research alternative remains genetically untested; yield honesty required (not high-yield marketing).
mast cell(1)
CQ-005Clinician questionmast cellresearch priority: highdon’t-miss review priority●Source audited
Can high-sensitivity peripheral-blood KIT D816V testing be performed with specimen, method, and limit of detection documented?
Rationale. Prior KIT-negative report lacks method/LOD; consensus mast-cell diagnostic pathways require sensitive KIT D816V methods. Negative results without documented assay quality do not fully exclude low-burden disease. (HαT explains basal tryptase separately and is not a substitute citation for KIT methodology.)
immunology(1)
CQ-006Clinician questionimmunologyresearch priority: highdon’t-miss review priority●Source audited
Is same-lab, same-assay pre/post pneumococcal polysaccharide vaccine challenge (± Hib as directed) appropriate to adjudicate specific antibody deficiency, given baseline non-protective titers and IgG1-low pattern?
Rationale. Baseline titers are not a vaccine-challenge study; formal SAD criteria require response assessment and infection history.
metabolic(1)
CQ-007Clinician questionmetabolicresearch priority: mediumdon’t-miss review priority●Source audited
Should serum copper, ceruloplasmin, and zinc be measured as a don’t-miss screen for copper-deficiency myeloneuropathy (which can lack cytopenias)?
Rationale. Copper not documented in public pack; copper-deficiency myeloneuropathy can present with neurologic findings and may lack frank cytopenias. Zinc excess is a risk context. Wilson disease (copper overload) is a different problem and is not the citation basis here.
neurology(1)
CQ-008Clinician questionneurologyresearch priority: medium●Source audited
Is an objective small-fiber/autonomic battery (e.g., exam + IENFD ± QST/QSART ± tilt as clinician-directed) appropriate given residual pain with normal large-fiber EMG, without treating symptoms alone as SFN diagnosis?
Rationale. Modern SFN criteria require objective testing; symptoms alone are insufficient.
infectious disease(1)
CQ-009Clinician questioninfectious diseaseresearch priority: mediumdon’t-miss review priority●Source audited
If infection is re-adjudicated, are reference Babesia thin smear + PCR during symptoms and Bartonella culture/PCR/IFA (or tissue only if a safe target exists) the appropriate instruments — rather than IgM churn or post-antibiotic FISH as primary adjudicators?
Rationale. IDSA babesiosis: smear or PCR for confirmation. Specialty FISH/IgM remain contested LDTs; commercial PCR/IB negative on pack.
endocrine(1)
CQ-010Clinician questionendocrineresearch priority: medium●Source audited
Can original hypogonadism-era HPG laboratory reports (around historical T≈34) be reconstructed, and is karyotype/CMA appropriate when clinically indicated?
Rationale. Historical T≈34 is reported_history with incomplete instrument provenance; Endocrine Society hypogonadism guidance informs HPG-axis reconstruction. Karyotype/CMA is a separate cytogenetic indication question (e.g., Klinefelter workup pathways), not established by testosterone-therapy guidelines alone.
Unresolved record questions (20)
Gaps in the documentary record, not questions for a clinician to answer. Each one names a document that has not been retrieved. Absence of a record is never a negative finding.
Closable only by patient, laboratory, clinician, or facility records — not by further reasoning over what is already published.
Still blocks launch-critical wording (8)
Until the named document is retrieved, these questions constrain how a public statement on this site may be worded.
UQ-0001Unresolved record questionstatus: open
KIT assay method
What was the exact KIT assay for the reported negative result — specimen type, method (ASO-qPCR, ddPCR, NGS, other), laboratory, and limit of detection?
Why it matters. Low-burden systemic mastocytosis exclusion depends on assay sensitivity; "KIT negative" without method is incomplete for public certainty language.
Closest available record. Narrative statements of KIT-negative in thiamine summary, medical-psychological history PDF, evidence pack, ledger T036 — no method sheet.
UQ-0003Unresolved record questionstatus: open
Original hypogonadism-era HPG labs
Can original laboratory reports for total testosterone ≈34 ng/dL (reportedly ×2) be retrieved with dates, assay methods, and concurrent LH, FSH, prolactin, estradiol, SHBG?
Why it matters. Distinguishes reported history from instrument-verified values; informs central vs primary hypogonadism and Klinefelter pretest probability.
Closest available record. Narrative ~34 ng/dL in endocrine/thiamine/ID summaries; tabulated HPG from 2021 onward.
UQ-0006Unresolved record questionstatus: open
Fragility-fracture characterization of pars defects
Do treating clinicians characterize L5 pars defects as fragility fractures meeting formal osteoporosis diagnostic criteria for a young male, or as stress/isthmic lesions?
Why it matters. Affects public "fragility fracture" language and diagnostic criteria claims.
Closest available record. Imaging "pars fractures"; thiamine timeline "atraumatic facet fractures".
UQ-0007Unresolved record questionstatus: open
Vaccine history and titer platform
What is the vaccine history (products, dates) behind Hib and 23-valent pneumococcal IgG titers, and which assay platform/lab produced the June 2026 panel?
Why it matters. Functional titers without challenge or history cannot confirm or refute SAD.
Closest available record. ID summary §2c — titers + explicit not-a-challenge note.
UQ-0008Unresolved record questionstatus: open
Dry beriberi formal diagnosis language
Did a licensed clinician document "dry beriberi" or equivalent as a formal diagnosis, or is the label solely patient-compiled / research interpretive language around documented thiamine deficiency and neuropathy?
Why it matters. Prevents overstating confirmed diagnosis vs lab deficiency + phenotype.
Closest available record. Thiamine summary pattern language; lab value 7 nmol/L.
UQ-0010Unresolved record questionstatus: open
Clinician osteoporosis diagnosis string
What exact diagnostic phrasing did treating clinicians use for the bone disease (e.g., osteoporosis, low BMD, idiopathic osteoporosis, osteopenia)?
Why it matters. Public site must not invent clinician diagnosis wording.
Closest available record. WHO-by-lowest-T language in bone summary only.
UQ-0015Unresolved record questionstatus: open
UTSW no-category statement
Is there a primary clinic note supporting "UTSW finds no clear category," and what was the exact scope of that evaluation?
Why it matters. README-level claim; easy to over-read as institutional diagnostic exhaustion.
Closest available record. README case snapshot prose only — not found in specialty PDFs reviewed.
Claims—Corrections—Hypotheses—
UQ-0017Unresolved record questionstatus: open
Infection specialty LDT vs independent confirmation
Can specialty Babesia FISH / Bartonella IgM signals be independently adjudicated with reference-method testing (Babesia smear+PCR during symptoms; Bartonella culture/PCR/IFA/tissue if clinician-indicated), without relying on post-antibiotic FISH or IgM churn?
Why it matters. Launch-critical infection wording requires dual-status specialty vs commercial pathways; H4 residual probability depends on proper adjudication instruments.
Closest available record. Infectious-disease summary §1a–1b tables; commercial PCR/IB negatives; specialty positives.
Open (12)
Open record gaps that do not currently constrain published wording. Openness is not a ranking of importance.
UQ-0002Unresolved record questionstatus: open
CTX pre-analytical conditions
Was serum CTX 616 pg/mL (2026-06-26) drawn fasting, at a standardized morning time, and on which assay platform?
Why it matters. CTX is sensitive to food intake and diurnal variation; affects turnover interpretation.
Closest available record. Bone density summary turnover table — value and ref only.
UQ-0004Unresolved record questionstatus: open
Early estradiol and treatment context
What were estradiol values, assay methods, and aromatase-inhibitor/SERM timing at the original hypogonadism presentation?
Why it matters. Limits causal narratives about estrogen handling; 2021–2026 E2 only partially available.
Closest available record. Endocrine summary HPG estradiol row + methodology note (5).
UQ-0005Unresolved record questionstatus: open
ALP age/sex reference audit
Do any historical ALP values fall below age- and sex-adjusted reference intervals (not only the adult 36–130 U/L band), and was bone-specific ALP ever measured?
Why it matters. Hypophosphatasia branch gating; total ALP mid-low normal is insufficient alone.
Closest available record. Endocrine CMP ALP 52/42/50 U/L within adult ref.
UQ-0009Unresolved record questionstatus: open
Facility DXA precision study / LSC source document
What is the facility-authored precision assessment document supporting LSC = 0.027 g/cm² (total hip) and 0.022 g/cm² (L3–L4 subregion), including software version?
Why it matters. Independent audit of "real loss" claim beyond patient-compiled footnote.
Closest available record. Bone density summary LSC footnotes.
UQ-0011Unresolved record questionstatus: open
Copper / ceruloplasmin / zinc results
Have serum copper, ceruloplasmin, and zinc been measured, and what were the results?
Why it matters. Don't-miss myeloneuropathy screen; currently a documented gap (S002/T110).
Closest available record. Ledger marks not in 2026 micronutrient extract; zinc normal on one panel.
Claims—Corrections—Hypotheses—
UQ-0012Unresolved record questionstatus: open
Karyotype / CMA
Has peripheral karyotype or chromosomal microarray been performed?
Why it matters. Closes XXY/mosaic question; available gonadotropin pattern leans central but not definitive.
Closest available record. Ledger T109 / S001 not in public pack.
Claims—Corrections—Hypotheses—
UQ-0013Unresolved record questionstatus: open
Rare-bone gene panel
Has an early-onset osteoporosis / OI-spectrum gene panel been run, and with what result?
Why it matters. Best single-primary hypothesis remains untested genetically.
Closest available record. Ledger T117 / S004 gap.
UQ-0014Unresolved record questionstatus: open
TPSAB1 copy number detail
What is the exact TPSAB1 copy-number genotype underlying the HαT-positive report?
Why it matters. Completeness of HαT claim; may affect tryptase-adjusted SM criteria discussions.
Closest available record. HαT positive statements; T114 incomplete.
UQ-0016Unresolved record questionstatus: open
Same-scanner software and positioning identity
For Site 1 serial DXA, were software version, analysis conventions, and positioning held constant across 2025-06-16 and 2026-06-19 hip scans?
Why it matters. Supports or weakens serial % change validity beyond LSC arithmetic.
Closest available record. Summary states "same Site 1 scanner" and Hologic Horizon Wi; software/positioning identity not independently documented.
UQ-0018Unresolved record questionstatus: open
Blood count after the change of testosterone treatment
Is there a complete blood count drawn after the patient switched from a selective estrogen-receptor modulator to injectable testosterone, and if so what are the hematocrit and hemoglobin values and their dates?
Why it matters. Raised hematocrit is the parameter the treatment guidelines already catalogued in this project name as the one to watch on testosterone therapy, and the most recent documented hematocrit sits near the top of its reference interval. The switch carries no date in either compiled summary, so the record cannot say whether any of the three documented blood counts was drawn after it. This is a gap in the record, not a finding: no documented value is abnormal, and nothing here suggests anything is wrong. The question is simply that the record does not establish whether it covers the period those guidelines watch.
Closest available record. Blood counts dated 2021-03-15, 2025-08-05 and 2026-06-19. The switch itself is described on camera and is placed only before the video's publication on 2026-08-03; neither compiled summary carries a date for it, and neither does the video.
UQ-0019Unresolved record questionstatus: open
Globulin below its printed reference floor, unflagged and glossed as low-normal
Was the globulin value of 1.8 g/dL reviewed against its printed 1.9-3.7 g/dL interval, and is there a protein electrophoresis or immunoglobulin panel from the same period that would show whether it reflects anything or is simply run-to-run variation?
Why it matters. The source document's table and its narrative disagree about this value. Resolving it needs either the underlying laboratory report or a clinician's read; it cannot be settled from the compiled summaries, because they are what disagree.
Closest available record. Endocrine summary comparison table (values 1.8, 1.9, 2.1 against 1.9-3.7) and the same document's narrative gloss "low-normal globulin". Rheumatology summary states globulin within range on its own later draws without printing the value.
UQ-0020Unresolved record questionstatus: open
Estradiol exposure over the aromatase inhibitor years is unmodeled and mostly unmeasured
What did estradiol actually do across the roughly two years of weekly an aromatase inhibitor (per the patient's video statement) - are there primary laboratory reports with assay method for that window, and was the 2021-03-15 sensitive-assay value of 9.3 pg/mL (8.0-35.0) typical of the exposure or a single low point?
Why it matters. Estradiol is the dominant sex-steroid determinant of bone mass in men, and aromatase inhibition in men measurably lowers bone density over a year of exposure (lit-0134), while short-term marker studies look reassuring (lit-0308) - duration is the crux. The exposure sits inside the bone-accrual-to-early-loss window this case turns on, it qualifies every "corrected axis" framing (which describes testosterone, not estradiol), and the compiled record holds only one sensitive-assay value from the whole window. The 2021 cessation was also a combined SERM-plus-AI stop, which bears on how the 2021 crash is read. None of this can be settled from the compiled summaries: the other estradiol values use a non-comparable immunoassay per the summary's own methodology note.
Closest available record. Endocrine summary p1 (regimen line; HPG table estradiol row: 9.3 on 2021-03-15, then 18, 22, 35, 25, 30 by standard immunoassay) and p4 note (5) on assay non-comparability; video transcript 00:15:52-00:16:27 (two-year duration, cessation without tapering).